Onyx Pharmaceuticals to Present at UBS Global Life Sciences Conference
EMERYVILLE, Calif. — Sep. 21, 2005
Contact:
Julie Wood
510-597-6505
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the UBS Global Life Sciences conference on Wednesday, September 28, at 4:30 p.m. Eastern Time. Interested parties may access a live webcast of the presentation at:
http://event.streamx.us/event/20050926
It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through October 28, 2005.
Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its collaborators, the company is developing small molecule drugs, including sorafenib with Bayer Pharmaceuticals Corporation. For more information about Onyx's pipeline and activities, visit the company's website at www.onyx-pharm.com.
Back to 2005 Press Releases
